Ubs Group Ag Surgalign Holdings, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.18 - $1.65 $8,647 - $79,266	48,040 Added 2570.36%	49,909 $8,000
Q1 2023 May 12, 2023	SELL	$1.57 - $2.79 $1,204 - $2,139	-767 Reduced 29.1%	1,869 $2,000
Q4 2022 Feb 08, 2023	BUY	$1.36 - $3.9 $1,763 - $5,058	1,297 Added 96.86%	2,636 $5,000
Q3 2022 Nov 10, 2022	SELL	$3.01 - $6.0 $66,530 - $132,618	-22,103 Reduced 94.29%	1,339 $4,000
Q2 2022 Aug 10, 2022	BUY	$3.38 - $9.0 $79,233 - $210,978	23,442 New	23,442 $80,000

Ticker SRGA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,746,500
Market Cap $67.5K
Description
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.